Search research articles
Contact Us
Filters
Showing results (1-10 of 185) with videos related to
Page
of 19
Sort By:
BJU International
|
January 24, 2018
Examining the role of centralisation of radical cystectomy for bladder cancer
Thomas Seisen
European Urology
|
December 14, 2016
Surgery-based Multimodal Management of High-risk Prostate Cancer Patients: What Is the Functional Price To Pay for Optimal Disease Control?
Thomas Seisen, Firas Abdollah
European Urology
|
January 30, 2023
Re: Maria S. Lindgren, Eric Hansen, Nessn Azawi, Anna M. Nielsen, Lars Dyrskjøt, Jørgen B. Jensen. DaBlaCa-13 Study: Oncological Outcome of Short-term, Intensive Chemoresection with Mitomycin in Nonmuscle Invasive Bladder Cancer: Primary Outcome of a Randomized Controlled Trial. J Clin Oncol. In press. https://doi.org/10.1200/JCO.22.00470
Benjamin Pradere, Giuseppe Basile, Thomas Seisen
European Urology
|
September 27, 2016
Reply to Hao Lun Luo, Yen Ta Chen, Yuan Tso Cheng, and Po Hui Chiang's Letter to the Editor re: Re: Thomas Seisen, Benoit Peyronnet, Jose Luis Dominguez-Escrig, et al. Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel. Eur Urol 2016;70:1052-68: The Key Role of Flexible Ureterorenoscopy in Kidney-sparing Surgery for Upper Tract Urothelial Carcinoma
Thomas Seisen, Marko Babjuk, Morgan Rouprêt
European Urology Oncology
|
January 27, 2023
Re: Jonas Hugosson, Marianne Månsson, Jona Wallström, et al. Prostate Cancer Screening with PSA and MRI Followed by Targeted Biopsy Only. N Engl J Med 2022;387:2126-37
Louis Lenfant, Pierre Mozer, Thomas Seisen
Nature Reviews. Urology
|
February 25, 2015
Risk-adapted strategy for the kidney-sparing management of upper tract tumours
Thomas Seisen, Pierre Colin, Morgan Rouprêt
European Urology
|
September 2, 2023
Re: Alexandre R. Zlotta, Leslie K. Ballas, Anderzej Niemierko, et al. Radical Cystectomy Versus Trimodality Therapy for Muscle-invasive Bladder Cancer: A Multi-institutional Propensity Score Matched and Weighted Analysis. Lancet Oncol 2023;24:669-81
Thomas Seisen, Morgan Rouprêt, Pierre Blanchard
European Urology Focus
|
September 3, 2018
Unmet Clinical Needs and Future Perspectives in Non-muscle-invasive Bladder Cancer
Riccardo Campi, Thomas Seisen, Morgan Roupret
World Journal of Urology
|
June 29, 2014
Surgical landscape of radical cystectomy for bladder cancer in France over the last 10 years
Priscilla Léon, Thomas Seisen, Morgan Rouprêt
Current Opinion in Urology
|
October 8, 2024
Novel intravesical therapies and delivery systems for the management of bladder cancer
Elisabeth Grobet-Jeandin, Morgan Rouprêt, Thomas Seisen
Page
of 19
Search research articles
Search
Showing results (1-10 of 185) with videos related to
Sort By:
Page
of 19
BJU International
|
January 24, 2018
Examining the role of centralisation of radical cystectomy for bladder cancer
Thomas Seisen
European Urology
|
December 14, 2016
Surgery-based Multimodal Management of High-risk Prostate Cancer Patients: What Is the Functional Price To Pay for Optimal Disease Control?
Thomas Seisen, Firas Abdollah
European Urology
|
January 30, 2023
Re: Maria S. Lindgren, Eric Hansen, Nessn Azawi, Anna M. Nielsen, Lars Dyrskjøt, Jørgen B. Jensen. DaBlaCa-13 Study: Oncological Outcome of Short-term, Intensive Chemoresection with Mitomycin in Nonmuscle Invasive Bladder Cancer: Primary Outcome of a Randomized Controlled Trial. J Clin Oncol. In press. https://doi.org/10.1200/JCO.22.00470
Benjamin Pradere, Giuseppe Basile, Thomas Seisen
European Urology
|
September 27, 2016
Reply to Hao Lun Luo, Yen Ta Chen, Yuan Tso Cheng, and Po Hui Chiang's Letter to the Editor re: Re: Thomas Seisen, Benoit Peyronnet, Jose Luis Dominguez-Escrig, et al. Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines Panel. Eur Urol 2016;70:1052-68: The Key Role of Flexible Ureterorenoscopy in Kidney-sparing Surgery for Upper Tract Urothelial Carcinoma
Thomas Seisen, Marko Babjuk, Morgan Rouprêt
European Urology Oncology
|
January 27, 2023
Re: Jonas Hugosson, Marianne Månsson, Jona Wallström, et al. Prostate Cancer Screening with PSA and MRI Followed by Targeted Biopsy Only. N Engl J Med 2022;387:2126-37
Louis Lenfant, Pierre Mozer, Thomas Seisen
Nature Reviews. Urology
|
February 25, 2015
Risk-adapted strategy for the kidney-sparing management of upper tract tumours
Thomas Seisen, Pierre Colin, Morgan Rouprêt
European Urology
|
September 2, 2023
Re: Alexandre R. Zlotta, Leslie K. Ballas, Anderzej Niemierko, et al. Radical Cystectomy Versus Trimodality Therapy for Muscle-invasive Bladder Cancer: A Multi-institutional Propensity Score Matched and Weighted Analysis. Lancet Oncol 2023;24:669-81
Thomas Seisen, Morgan Rouprêt, Pierre Blanchard
European Urology Focus
|
September 3, 2018
Unmet Clinical Needs and Future Perspectives in Non-muscle-invasive Bladder Cancer
Riccardo Campi, Thomas Seisen, Morgan Roupret
World Journal of Urology
|
June 29, 2014
Surgical landscape of radical cystectomy for bladder cancer in France over the last 10 years
Priscilla Léon, Thomas Seisen, Morgan Rouprêt
Current Opinion in Urology
|
October 8, 2024
Novel intravesical therapies and delivery systems for the management of bladder cancer
Elisabeth Grobet-Jeandin, Morgan Rouprêt, Thomas Seisen
Page
of 19